AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash

Date:




AbbVie has agreed to buy Apogee Therapeutics for about $10.9 billion in cash in a deal that bolsters the biopharmaceutical company’s immunology and inflammation portfolio.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Kelsea Ballerini Sticks Up For Stella Lefty After Opry Debut

Stella Lefty made her Grand Ole Opry debut on Wednesday...

Opinion | Make Mark Ruffalo Great Again

Trump’s plan to save Hollywood is sure to...